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Introduction
Tumor necrosis factor receptor-associated periodic syn-
drome (TRAPS) is characterized by periodic fever, cuta-
neous rash, conjunctivitis, lymphadenopathy, abdominal
pain, myalgia, and arthralgia. It is a rare autosomal
dominant disease and strongly associated with heterozy-
gous mutations in the tumor necrosis factor (TNF)
receptor super family 1A (TNFRSF1A) gene. The great
diversity of manifestations and the difficulties in genetic
analyses make the diagnosing of this disease a challenge.
Our aim was to report on case of autoinflammatory syn-
dromes that is considered to be rare entity.
Case report
A 16-year-old Caucasian boy presented at the age of 15
years with fever (39 ºC), weakness, lymphadenopathy,
splenomegaly and arthralgia. The laboratory tests
revealed anemia, leukocytosis, thrombocytosis, ESR of
80 mm, CRP of 90 mg/l (normal < 0.5). A diagnosis of
systemic juvenile idiopathic arthritis (JIA) was made and
the patient was treated with corticosteroids, NAIDs and
gamma globulin. Over the next 6 months, he presented
skin rash regarded as reaction to drugs. No abdominal
pain or conjunctivitis was noted. Pulse therapy with
methylprednisolone and constant administration NAIDs
were needed to control fever and pain. After extensive
work-up of infectious etiology, an oncological disease
with negative results he underwent diagnostic laparo-
scopic surgery for lymph node biopsy because of
abdominal lymphadenopathy, without findings. Ques-
tioned further autoinflammatory syndrome was sus-
pected. DNA analysis showed a mutation present in
exons 9 of the TNFRSF1A gene (deletion c.792delT),
thus resulting in a diagnosis of TRAPS. He had partial
clinical response to corticosteroids. However, the
treatment response to TNF-a inhibitor infliximab was
dramatic. At the present he still presents rash but no
fever and lymphadenopathy.
Discussion
Here, we report a patient with TRAPS who recovered
from steroid dependency by infliximab and kept remis-
sion with infliximab. The patient was thought to have
had systemic JIA. Failure to respond to therapy, good
response only to very high doses of corticosteroids led
us to suspect autoinflammatory syndrome. Clinical fea-
tures are important for the diagnosis, but confirmation
is obtained through genetic analysis. Autoinflammatory
syndromes should be considered in patients with fever
of unknown origin and the clinicians must be aware of
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